Poulvac Maternavac IBD-ReoThis page contains information on Poulvac Maternavac IBD-Reo for veterinary use.
The information provided typically includes the following:
- Poulvac Maternavac IBD-Reo Indications
- Warnings and cautions for Poulvac Maternavac IBD-Reo
- Direction and dosage information for Poulvac Maternavac IBD-Reo
Poulvac Maternavac IBD-ReoThis treatment applies to the following species:
Bursal Disease-Reovirus Vaccine
Standard and Variant, Killed Virus
For Veterinary Use Only
For the revaccination of healthy chickens as an aid in the prevention of the signs and lesions associated with infectious bursal disease caused by standard and variant strains and avian reovirus infections which cause malabsorption syndrome. Progeny of vaccinates are aided in the prevention of signs and lesions associated with infectious bursal disease and reovirus disease via maternal antibodies.
DOSE: Inject 0.5 mL (0.5 cc) intramuscularly or subcutaneously (in the lower neck region) using aseptic technique. Vaccinate only healthy birds. For primed birds, a single dose between 16 and 22 weeks (approximately 4 weeks prior to lay) is indicated.
Poulvac Maternavac IBD-Reo Caution
Store in the dark at 2° to 7°C (35° to 45°F). Do not freeze. Warm to 22°C (72°F) and shake well before using. Do not vaccinate within 42 days before slaughter. Use entire contents when first opened.
Gentamicin and amphotericin B added as preservatives.
WarningIn case of accidental human injection seek immediate medical attention.
Zoetis Inc., Kalamazoo, MI 49007
U.S. Vet. License No. 190
NAC No.: 36903122
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Poulvac Maternavac IBD-Reo information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-08-31